thiotepa has been researched along with AIDS-Associated Lymphoma in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schorb, E | 1 |
| Fox, CP | 1 |
| Kasenda, B | 1 |
| Linton, K | 1 |
| Martinez-Calle, N | 1 |
| Calimeri, T | 1 |
| Ninkovic, S | 1 |
| Eyre, TA | 1 |
| Cummin, T | 1 |
| Smith, J | 1 |
| Yallop, D | 1 |
| De Marco, B | 1 |
| Krampera, M | 1 |
| Trefz, S | 1 |
| Orsucci, L | 1 |
| Fabbri, A | 1 |
| Illerhaus, G | 1 |
| Cwynarski, K | 1 |
| Ferreri, AJM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Studio Osservazionale Retrospettivo Multicentrico Sull'Utilizzo di Ibrutinib in Monoterapia o in Associazione a Immunochemioterapia Secondo Schema R-CHOP in Pazienti Adulti Con Diagnosi di PCNSL Ricaduto o Refrattario[NCT05782374] | 36 participants (Anticipated) | Observational | 2022-08-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for thiotepa and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous Syst | 2020 |